Atlas Trials

PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI

Clinical trial NCT02479490 · TERMINATED

Trial details

NCT number
NCT02479490
Sponsor
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Renal Cancer
Start date
2015-09-22
Primary completion
2017-05-05
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.